Unbound MEDLINE

Chemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI. AJR. American journal of roentgenology [AJR Am J Roentgenol] Journal article

 
TitleChemoembolization of hepatic metastases from ocular melanoma: assessment of response with contrast-enhanced and diffusion-weighted MRI.
Author(s)Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JF, Kamel IR 
InstitutionRussell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Hospital, 601 N Caroline St., Rm. 3235A, Baltimore, MD 21287, USA.
SourceAJR Am J Roentgenol 2008 Jul; 191(1):285-9.
MeSHAged
Chemoembolization, Therapeutic
Contrast Media
Diffusion Magnetic Resonance Imaging
Eye Neoplasms
Female
Gadolinium DTPA
Humans
Liver Neoplasms
Male
Melanoma
Outcome Assessment (Health Care)
Prognosis
Treatment Outcome
AbstractOBJECTIVE: The purpose of this study was to assess the utility of assessment of tumor size and enhancement with diffusion-weighted and conventional MRI in the evaluation of response to transarterial chemoembolization therapy for metastatic ocular melanoma.
CONCLUSION: In patients with ocular melanoma and liver metastasis treated with transarterial chemoembolization, functional MRI showed significant changes in the lesions. These changes included a decrease in tumor enhancement and an increase in the apparent diffusion coefficient of the tumor, suggesting increasing tumor necrosis and cell death.
Languageeng
Pub Type(s)Journal Article
PubMed ID18562760
  
Advertise on this site.